Health Condition 1: O679- Intrapartum hemorrhage, unspecified
Conditions
Interventions
Intervention1: CARBETOCIN: IV 100 mcg given bolus over 1 minute followed by 1.5 ml distilled water in 500 ml normal saline drip
Control Intervention1: OXYTOCIN: IV bolus 5 IU over 1 minute, followed b
Sponsors
Jawaharlal Nehru Medical College And Datta Meghe Institute Of Higher Education And Research
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with age between 18-35 years Females. 2)Patients with ASA grade I, II. 3)Patient posted for cesarean section under spinal anesthesia. 4)Singleton pregnancy 5)Term gestation 6)Decision made for a cesarean section in labor 7)Who have given consent
Exclusion criteria
Exclusion criteria: 1)Patients with ASA grade III, IV. 2)Women with known coagulopathy 3)Study drug hypersensitivity 4)Olygohydromnios or polyhydromnios 5)Cardiac disease (including dysarythmia) 6)Hypertension 7)Liver, renal or endocrine disease (except gestational diabetes) 8)Uterine fibroids or suspicion of placental pathology (accreta, previa or abruptio)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Carbetocin Is More Effective As Compared To Oxytocin In Reducing Intraoperative Bleeding During Cesarean SectionTimepoint: 3 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| The use of Carbetocin reduces the requirement for additional uterotonics and surgical maneuvers during cesarean sections in preventing uterine atony and intraoperative hemorrhage.Timepoint: 3 Years | — |
Countries
India
Contacts
Public ContactDR VINIT DHANURE
Datta Meghe Institution Of Higher Education And Research
Outcome results
None listed